Relief Therapeutics Holding AG (RLFTF)

[whosjohngalt]

seems a weekly recap of events

discussed here already. Can't get the whole article, not a member

Mirabaud's pharmaceutical analyst has advised against buying relief shares after a competitor's trial failed. The Chairman of the Board of Directors takes a position.

Shares of Relief Therapeutics lost nearly a quarter of their value on Tuesday, while on Wednesday it fell to a similar extent. The trigger appears to have been an article published by "Finance and Economics" in advance of the expected recommendation of the Data Monitoring Committee.

The Committee supervises the implementation of the study with Relief's active substance RLF-100 (Aviptadil). It is being tested in the US on hospitalized corona patients who need to be ventilated. On Thursday, the committee voted in favour of continuing the study. The share price has since made up for a large part of the loss.